Salutary Effects of Dietary Supplementation With OMEGA 3 on Exercise Performance and Endothelial Function in Patients With Congestive Heart Failure. A Matter of Lipid Oxidation?
Phase of Trial: Phase III
Latest Information Update: 04 Jun 2016
At a glance
- Drugs Omega-3-acid ethyl esters (Primary)
- Indications Heart failure
- Focus Pharmacodynamics
- 16 Apr 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 14 Feb 2012 Planned end date changed from 1 Jul 2012 to 1 Feb 2013 as reported by ClinicalTrials.gov.
- 19 Jul 2011 Actual initiation date (Jul 2009) added as reported by ClinicalTrials.gov.